Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein for 65-year-olds and Above

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(8 sites)

China

The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui

Anhui Chest Hospital, Hefei, Anhui

Guangzhou Municipal Hospital of Chest Medicine, Guangzhou, Guangdong

The Third People's Hospital Of Shenzhen, Shenzhen, Guangdong

LiuZhou People's Hospital, Liuchow, Guangxi

Changsha Central Hospital, Changsha, Hunan

Wuxi NO.5 People's Hospital, Wuxi, Jiangsu

Wuhan Institute for Tuberculosis Control, Wuhan